Skip to main content

Table 4 OLS regression predicting comorbidity score, adjusting for demographics and health characteristics, (N = 17,961)

From: Characteristics of U.S. adults taking prescription antipsychotic medications, National Health and Nutrition Examination Survey 2013–2018

 

Model 1

Model 2

b

95% CI

p-value

b

95% CI

p-value

Taking antipsychotic medication

0.32

(0.17,0.48)

< 0.001

0.26

(0.10,0.41)

0.002

Age

0.04

(0.04,0.04)

< 0.001

0.03

(0.03,0.04)

< 0.001

Female

−0.11

(−0.15,-0.07)

< 0.001

−0.11

(− 0.16,− 0.07)

< 0.001

Race/ethnicity (NH white = ref)

 NH black

0.05

(0.00,0.09)

0.036

0.07

(0.03,0.12)

0.001

 Hispanic

-0.07

(−0.11,-0.02)

0.006

0.01

(−0.04,0.05)

0.706

 Other race

−0.05

(−0.12,0.02)

0.141

− 0.02

(− 0.09,0.05)

0.514

Have a usual place for health care

   

0.24

(0.20,0.29)

< 0.001

Insured

   

0.14

(0.08,0.19)

< 0.001

Smoking (Never = ref)

 Former smoker

   

0.19

(0.15,0.24)

< 0.001

 Current smoker

   

0.21

(0.16,0.25)

< 0.001

r-squared

0.323

  

0.339